519606 — Integrated Proteins Income Statement
0.000.00%
- IN₹142.14m
- IN₹180.23m
- IN₹214.96m
- 13
- 45
- 42
- 21
Annual income statement for Integrated Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS |
Standards: | IAS | IAS | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1.67 | 2.37 | 215 |
Cost of Revenue | |||
Gross Profit | 0.2 | 0.151 | 4.71 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 2.81 | 3.83 | 214 |
Operating Profit | -1.14 | -1.45 | 0.82 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 0.418 | 1.04 | 3.19 |
Provision for Income Taxes | |||
Net Income After Taxes | 0.309 | 0.893 | 2.5 |
Net Income Before Extraordinary Items | |||
Net Income | 0.309 | 0.893 | 2.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 0.309 | 0.893 | 2.5 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.096 | 0.031 | 0.71 |